Definitive Contract 75N95022C00042
Award Date
9/30/22
Potential Completion Date
9/29/27
Potential Value
$357K
Funding Federal Agency
National Institute of Neurological Disorders and Stroke
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
The Broad Institute, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
R499 - Support- Professional: Other
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, is valued at $1,285.00 and has no set-aside designation. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) for "OTHER FUNCTIONS SEQUENCING SERVICE." The Broad Institute is a non-profit biomedical and genomic research organization that partners with universities, medical centers, and companies to advance the understanding of human...
This federal contract award, valued at $81,600.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the U.S. Department of Health and Human Services. The contract was awarded to The Broad Institute, Inc., a non-profit biomedical and genomic research organization, to perform whole genome DNA sequencing of 32 mouse genomes. This work is being conducted at The Broad Institute's facilities in Cambridge, Massachusetts. The contract...
This is a federal contract award valued at $394,227.01 to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, a non-profit biomedical and genomic research organization. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), for TAS::75 0885::TAS BIOMEDICAL (APPLIED/EXPLORATORY) services. The contract has no set-aside designation. The Broad Institute frequently partners...
This firm fixed-price purchase order for $108,629.18 was awarded by the National Institute of Environmental Health Sciences, a civilian agency, to The Broad Institute, Inc. for whole exome sequencing services. The contract has no set-aside designation, reflecting The Broad Institute's competitive capabilities in advanced genomic research and data analysis services. The Broad Institute has performed similar work for other federal agencies like the Centers for Disease Control and Prevention,...
This is a $37,876,167 Firm Fixed Price definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI) to The Broad Institute, Inc., a non-profit research organization. The contract supports the Trans-Omics for Precision Medicine (TOPMed) initiative through genomics data generation, analysis, and management services. This is an indefinite delivery contract with a 10-year, $500 million ceiling. The Broad Institute was also awarded a multiple-award Indefinite Delivery Indefinite...
This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency, to The Broad Institute, Inc. doing business as Broad Institute of MIT and Harvard, a non-profit biomedical and genomic research organization. The $241,554.00 contract is for procode-based strategies for large-scale imaging of induced pluripotent stem cells (iPSCs) and iPSC-derived cell types. The Broad Institute has received numerous prime and subcontract awards from agencies like the...
This $202,500 firm-fixed price purchase order was awarded to The Broad Institute, Inc. by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract is for whole genome sequencing of sickle cell patient blood samples, with a completion date of September 21, 2025. The Broad Institute is a non-profit biomedical and genomic research organization that frequently partners with government agencies like NIH, CDC, and DoD to provide...
This federal contract award, valued at $166,819,979.48, was issued by the National Cancer Institute (NCI) to The Broad Institute, Inc. (doing business as Broad Institute of MIT and Harvard), a non-profit biomedical and genomic research organization. The contract is for the Sequencing for the Cancer Genome Atlas (TCGA) Program, which supports the generation and analysis of genomic data to advance cancer research. The Broad Institute will provide a range of scientific services, including genomic...
This is a delivery order under a multi-year, multi-award Indefinite Delivery Contract (IDC) awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Broad Institute of MIT and Harvard. The $24,910,368.70 firm fixed-price task order is for the Broad Institute to provide genomics data generation, analysis, and management services in support of the NHLBI's Trans-Omics for Precision Medicine (TOPMed) initiative. This work will...
This federal contract award was issued by the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The $2,343,147.64 firm fixed price contract is a delivery order under the Centralized Omic REsource for TOPMed (CORE) indefinite delivery vehicle (IDV), which has a $500 million ceiling to support the Trans-Omics for Precision Medicine initiative through genomics data...